What is the CTNM stock price prediction for next 2 weeks?

According to our price prediction algorithm,Contineum Therapeutics, Inc. Class A Common Stock (CTNM) price will be around $14.02 in the next 2 weeks. This means it will decrease by -0.920141342756186 from the last closing price. This prediction may vary from other time period filters for CTNM stock.

What can be the highest Possible price of CTNM stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CTNM can achieve the highest price of $14.69 which is 3.8386909324997514 higher than last closing price. This prediction may vary from other time period filters for CTNM stock.

What can be the lowest Possible price of CTNM stock in next 2 weeks?

As per the forecast and algorithmic analysis, CTNM stock price can be as low as $13.33 which is -5.778645672245147 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CTNM stock.

Will CTNM stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CTNM stock will lose-0.920141342756186 in the next 2 weeks. This prediction may vary from other time period filters for CTNM stock.

What is CTNM stock last closing price?

Last closing price of CTNM stock was $14.15.

What is CTNM stock price prediction?

CTNM stock price prediction means predicting the future closing prices of CTNM stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CTNM stock in a certain time period.

How we predict CTNM stock future prices?

If you are searching for CTNM stock forecast, analysis or price prediction, then you might be wondering what Contineum Therapeutics, Inc. Class A Common Stock (CTNM) will do in the future. Our CTNM price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CTNM price prediction will likely answer most of your questions.

How frequent we update CTNM stock predictions?

We are updating the forecasts for the CTNM stock on daily basis.

Is using ML forecasting for CTNM stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CTNM stock same for all the time periods?

No, the prediction for CTNM stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Contineum Therapeutics, Inc. Class A Common Stock Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$14.157.6%Since 2 Weeks

Predicted Price$14.02-0.92%For 2 Weeks

Upper Predicted Price$14.693.84%For 2 Weeks

Lower Predicted Price$13.33-5.78%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CTNM will decline by -0.92% over the next 2 Weeks and hit $14.02 by Monday, May 18, 2026. In that time frame, CTNM's share price is expected to range between $13.33 and $14.69.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 18, 2026	13.33	14.02	14.69
May 15, 2026	13.29	13.99	14.68
May 14, 2026	13.40	14.05	14.82
May 13, 2026	13.44	14.16	14.84
May 12, 2026	13.36	13.99	14.63
May 11, 2026	13.39	14.08	14.77
May 8, 2026	13.36	14.05	14.71
May 7, 2026	13.43	14.12	14.78
May 6, 2026	13.51	14.22	14.86
May 5, 2026	13.36	14.06	14.78

CTNM shares rose +7.20% in Monday, May 4, 2026's trading session, rising from a previous close of $13.20 to move at $14.15. The stock demonstrated notable intraday movement (see CTNM's key stats for a full breakdown), fluctuating between $12.84 and $14.53, a +13.16% trading range. While recent weeks have seen some volatility, CTNM has managed to secure a +4.58% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 538.27K shares changing hands, 258.49K more than the previous session. This amounted to $7.62M in total market activity.

Will CTNM Continue Its Upward Trend?

According to analyst ratings and projections for CTNM, Contineum Therapeutics, Inc. Class A Common Stock shares are anticipated to increase by +3.70%, potentially reaching $14.69 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for CTNM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CTNM stock forecast, now is a good time to buy CTNM stock because its current trading price is +0.93% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CTNM covering social and institutional perspectives.

CTNM Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CTNM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 56.67% to 66.23%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 53.42%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.95%, maintains a neutral outlook for the long term. Insights into CTNM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Contineum Therapeutics Class A Common Stock Short-Term Forecasts

CTNM Forecast For Next 5 Days

Our algorithm anticipates Contineum Therapeutics Class A Common Stock (CTNM) stock could hit $13.40 by May 12, 2026. This represents a -5.30% rise from today's price, following a +29.23% change over the past five days.

CTNM Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $13.09, which would mean a -7.49% decrease from the current price of $14.15. Projections for this period range from a high of $14.65 to a low of $11.18.

CTNM Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Contineum Therapeutics Class A Common Stock's price over the next three months point to a rise. CTNM stock is expected to peak at $43.71 on Jul 16, 2026 after potentially dipping to $17.55 on Jun 02, 2026. On average, CTNM is likely to trade around $31.13 in the coming 90 days.

Contineum Therapeutics Class A Common Stock Stock Forecast 2025

Based on our predictive models, Contineum Therapeutics Class A Common Stock (CTNM) is expected to trade between $17.55 and $53.51 throughout 2026. This would result in an average price of $37.85, potentially offering investors a +167.49% return from current levels.

Contineum Therapeutics, Inc. Class A Common Stock Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is positioned to show a strong performance in May 2026. The price is predicted to move between $17.97 and $27.87, settling at an average of $24.01. This could translate to a +69.68% gain.

June 2026

Based on current market signals, Contineum Therapeutics, Inc. Class A Common Stock is projected to trend june 2026. We forecast a trading range from $17.55 to $38.84, with a likely average price of $26.22. Investors could expect a potential return of +85.30%.

July 2026

Our predictive algorithms indicate Contineum Therapeutics, Inc. Class A Common Stock stock may see a shift in July 2026. The expected range spans $36.00–$43.71, with an average target of $41.29. This represents a positive outlook and a possible gain of +191.80%.

August 2026

Analyzing established trends, Contineum Therapeutics, Inc. Class A Common Stock looks set to move in August 2026. Projections place the stock between $31.96 and $42.65, averaging around $35.31. This suggests a +149.54% gain from current levels.

September 2026

Market indicators suggest Contineum Therapeutics, Inc. Class A Common Stock could experience notable changes during September 2026. Prices could fluctuate within $41.22 to $48.73, with a midpoint forecast of $44.95. The stock might deliver a +217.67% gain.

October 2026

Forecasting for October 2026, models estimate that Contineum Therapeutics, Inc. Class A Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $32.44 and $47.48, averaging $39.32. This signals a positive trajectory with potential returns around +177.88%.

November 2026

According to our latest forecast models, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is positioned to show a strong performance in November 2026. The price is predicted to move between $33.68 and $51.18, settling at an average of $41.48. This could translate to a +193.14% gain.

December 2026

Based on current market signals, Contineum Therapeutics, Inc. Class A Common Stock is projected to trend december 2026. We forecast a trading range from $43.00 to $53.51, with a likely average price of $47.80. Investors could expect a potential return of +237.81%.

January 2027

Our predictive algorithms indicate Contineum Therapeutics, Inc. Class A Common Stock stock may see a shift in January 2027. The expected range spans $39.14–$46.11, with an average target of $40.53. This represents a positive outlook and a possible gain of +186.43%.

February 2027

Analyzing established trends, Contineum Therapeutics, Inc. Class A Common Stock looks set to move in February 2027. Projections place the stock between $41.69 and $50.31, averaging around $43.42. This suggests a +206.86% gain from current levels.

March 2027

Market indicators suggest Contineum Therapeutics, Inc. Class A Common Stock could experience notable changes during March 2027. Prices could fluctuate within $31.16 to $47.58, with a midpoint forecast of $36.64. The stock might deliver a +158.94% gain.

April 2027

Forecasting for April 2027, models estimate that Contineum Therapeutics, Inc. Class A Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $31.51 and $53.54, averaging $39.57. This signals a positive trajectory with potential returns around +179.65%.

May 2027

According to our latest forecast models, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is positioned to show a strong performance in May 2027. The price is predicted to move between $48.95 and $54.58, settling at an average of $47.97. This could translate to a +239.01% gain.

CTNM's history of dividends and stock splits also plays a role in long-term investor confidence.